Biotechnology continues to march forward with new treatments, research and development and technologies that directly impact and improve lives. The best place to learn where the industry is headed and how it is going to get there is at the 2020 BIO International Convention in San Diego, June 8-11. Education programming for BIO 2020 was announced this week and includes new educational tracks that keep pace with the ever-changing world of biotechnology.
The wide-ranging program covers everything from business development to the most recent scientific discoveries, to patient access, to government policy and more. With nearly 150 breakout sessions, super sessions, fireside chats, town halls and keynotes planned, almost no stone is left unturned in the search for what’s hot in biotechnology today.
Focus on Patients
Common throughout the educational programming is the drive to advance new treatments and cures to improve the lives of those impacted by disease, disorders and illness. Delivering transformative medicines to the people who need them is the overriding goal for the biotech industry and BIO 2020 offers ample panel sessions to help these companies reach that goal.
Education Tracks for Every Attendee
Throughout BIO 2020 we will cover trending topics in business development and in scientific discovery. A new track this year is Cell & Gene Therapies and Genome Editing. Progress in both gene therapy and genome editing over the past several years prompted the creation of this new track which will cover a broad range of topics including:
- Manufacturing gene therapies
- Bioethics considerations
- Commercialization of personalized medicine
Building from prior years, the digital health track continues to expand. The potential for better tools for clinical trials, patient outcome tracking and capturing real world evidence will come from digital applications gaining momentum in the near future. The Digital Health track will cover such issues as health coverage for digital applications, regulation, digital biomarkers and more.
Since therapies and treatments are only useful if they hit the marketplace, the Business Development and Finance track provides insights from experts on how to navigate the journey from discovery to the market. Sessions will cover deal making, attracting good talent, IP, persuasive pitching, and driving efficiency.
World Class Speakers
While the full line-up of speakers is still in development, several have been announced. They include:
- Jeff Allen, President and CEO, Friends of Cancer Research
- Denise Faustman, Head of Immunobiology Lab, Mass General Hospital
- Natalie Holles, President and Chief Executive Officer, Audentes, an Astellas Company
- Nina Kjellson, General Partner, Caanan Partners
- Jeff Kutok, Chief Scientific Officer, Infinity
- Peter Lee, Corporate Vice President, Microsoft Healthcare
- Peter Marks, MD, Director, Center for Biologics, Evaluation and Research, Food and Drug Administration
Featured BIO 2020 Speakers
Unmatched Partnering Opportunities
BIO One-on-One Partnering™ will open early April. The versatile system is one of the biggest draws to the Convention, allowing users to create profiles containing company presentations, clinical trial data, YouTube videos—anything that will show what the organization is about and help it reach its target audience. This year, the system is expected to facilitate nearly 50,000 meetings.
The 2020 BIO International Convention—the world’s largest biotech partnering event—keeps getting better and the panel sessions are as compelling as the industry it represents.
Complimentary media registration is open and available to qualified reporters working full time for print, broadcast, and web publications with valid press credentials.